Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

HGH 191AA Dosing Protocol: 10 IU Vial — Daily Dosing &

HGH 191AA 10 IU vial: 10 IU/mL, 1–4 IU daily (10–40 units). IGF-1 and glucose monitoring. Anti-aging and body composition. Reviewed Feb 2026. Reviewed Feb 2026.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

HGH 191AA Dosing Protocol: 10 IU Vial — Daily Dosing Schedule & Supplies

Recombinant human growth hormone (HGH 191AA) dosing guide for the 10 IU compounded vial, with concentration calculations and reconstitution steps.

Quickstart highlights

Recombinant human growth hormone (somatropin, 191 amino acids) is identical to endogenous pituitary GH.

Concentration: 10 IU/mL (10 IU vial + 1 mL bacteriostatic water).

At 10 IU/mL: 1 IU = 10 units, 2 IU = 20 units, 4 IU = 40 units on a U-100 syringe.

One 10 IU vial provides 10 daily doses at 1 IU or 2.5 doses at 4 IU daily.

Monitor fasting glucose weekly at doses ≥2 IU/day — HGH causes dose-dependent insulin resistance.

WADA-prohibited in sport; not approved for off-label wellness use by FDA.

Dosing table

For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.

1-4

—

10

Once daily (morning)

1 IU — 10 units on U-100; conservative start for anti-aging protocol; one 10 IU vial provides 10 doses

5-8

20

Once daily

2 IU — 20 units; standard body composition dose; 5 doses per vial

9-16

30

3 IU — 30 units; upper anti-aging dose; 3–4 doses per vial

17+

40

4 IU — 40 units; performance protocol ceiling; 2.5 doses per vial

Gradual approach

1-8

5

0.5 IU — 5 units; ultra-conservative start for women or older adults (>60); assess glucose tolerance

1 IU — advance only if fasting glucose unchanged from baseline

Your free HGH 191AA tracker

Dose reminders

Injection logging

Cycle progress

Reconstitution steps

Draw 1 mL bacteriostatic water into a 3 mL syringe; inject slowly down the vial wall — do not inject directly onto the lyophilized pellet.

Allow to dissolve naturally (do not shake); gently swirl if needed — 1–3 minutes.

Final concentration: 10 IU/mL. At this concentration, 1 IU = 10 units on a U-100 syringe.

Label with date and concentration; refrigerate at 2–8 °C immediately. Use within 28 days.

Supplies needed

8-week plan

2 vials

56 syringes

2 mL bac water

56 alcohol swabs

16-week plan

6 vials

112 syringes

6 mL bac water

112 alcohol swabs

Protocol overview & cycle notes

Achieve GH-mediated body composition improvements (fat loss, lean mass gain) and anti-aging effects through precisely dosed daily subcutaneous HGH injections, starting at 1 IU and titrating based on IGF-1 response and glucose tolerance.

Cycle length: 16 weeks on.

Off-cycle: 4–8 weeks off per cycle; check IGF-1 and fasting glucose before resuming.

Storage & handling

Injection & tracking tips

Inject subcutaneously on an empty stomach in the morning (pre-breakfast) for optimal GH/lipolysis synergy; alternatively, inject in the evening 2+ hours after last meal.

Use a short, fine-gauge needle: 29G–31G, 4–6 mm length for subcutaneous abdominal injection.

NEVER inject into a vein — strictly subcutaneous administration only.

Tracking

Logging helps you and your provider spot patterns and adjust dose or timing.

Check fasting glucose weekly for the first 8 weeks — HGH causes insulin resistance at doses ≥2 IU/day.

Measure IGF-1 at baseline and every 4 weeks — target upper-normal range for age (<250 ng/mL for adults over 40).

Track body composition (lean mass, body fat %) via InBody or DEXA every 8 weeks.

How this works & references

Sources

Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. Johannsson G et al. — J Clin Endocrinol Metab — 1997

FDA — Genotropin (somatropin) Prescribing Information

Frequently asked questions

Related protocols

KLOW Blend Dosing Protocol — BPC-157, TB-500, KPV & GHK-Cu Guide

KLOW peptide blend (BPC-157 + TB-500 + KPV + GHK-Cu) dosing guide for tissue repair, anti-inflammatory support, and extracellular matrix remodeling — the GLOW blend plus KPV.

GLOW Blend Dosing Protocol — BPC-157, TB-500 & GHK-Cu Skin & Repair Guide

GLOW peptide blend (BPC-157 + TB-500 + GHK-Cu) dosing guide for tissue repair, angiogenesis, and collagen and connective-tissue remodeling.

Vilon Dosing Protocol: 20 mg Vial — Dipeptide Immune & Longevity Bioregulator Guide

Vilon (Lys-Glu dipeptide) Russian immune and longevity bioregulator dosing guide — the simplest Khavinson bioregulator for systemic immune normalization and longevity support.

Vesugen Dosing Protocol: 20 mg Vial — Vascular Bioregulator & Cardiovascular Guide

Vesugen (Lys-Glu-Asp tetrapeptide) Russian vascular bioregulator dosing guide — endothelial cell gene normalization for arterial health, blood pressure regulation, and cardiovascular aging.

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.

Need help?

Connected topics

Follow this recovery question